Literature DB >> 15181484

Use of resampling to select among alternative error structure specifications for GLMM analyses of repeated measurements.

Scott Tonidandel1, John E Overall, Fraser Smith.   

Abstract

Autocorrelated error and missing data due to dropouts have fostered interest in the flexible general linear mixed model (GLMM) procedures for analysis of data from controlled clinical trials. The user of these adaptable statistical tools must, however, choose among alternative structural models to represent the correlated repeated measurements. The fit of the error structure model specification is important for validity of tests for differences in patterns of treatment effects across time, particularly when maximum likelihood procedures are relied upon. Results can be affected significantly by the error specification that is selected, so a principled basis for selecting the specification is important. As no theoretical grounds are usually available to guide this decision, empirical criteria have been developed that focus on mode fit. The current report proposes alternative empirical criteria that focus on bootstrap estimates of actual type I error an power of tests for treatment effects. Results for model selection before and after the blind is broken are compared. Goodness-of-fit statistics also compare favourably for models fitted to the blinded or unblinded data, although the correspondence to actual type I error and power depends on the particular fit statistic that is considered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181484      PMCID: PMC6878445          DOI: 10.1002/mpr.161

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  9 in total

1.  Modeling the covariance structure in pharmacokinetic crossover trials.

Authors:  J K Lindsey; J Wang; W D Byrom; B Jones
Journal:  J Biopharm Stat       Date:  1999-08       Impact factor: 1.051

2.  Issues in use of SAS PROC.MIXED to test the significance of treatment effects in controlled clinical trials.

Authors:  C Ahn; S Tonidandel; J E Overall
Journal:  J Biopharm Stat       Date:  2000-05       Impact factor: 1.051

3.  Problematic formulations of SAS PROC.MIXED models for repeated measurements.

Authors:  J E Overall; C Ahn; C Shivakumar; Y Kalburgi
Journal:  J Biopharm Stat       Date:  1999-03       Impact factor: 1.051

4.  Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design.

Authors:  L Frison; S J Pocock
Journal:  Stat Med       Date:  1992-09-30       Impact factor: 2.373

Review 5.  An example of using mixed models and PROC MIXED for longitudinal data.

Authors:  R D Wolfinger
Journal:  J Biopharm Stat       Date:  1997-11       Impact factor: 1.051

6.  Drop-outs and a random regression model.

Authors:  J E Overall
Journal:  J Biopharm Stat       Date:  1997-07       Impact factor: 1.051

7.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

8.  Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.

Authors:  Jonathan RT Davidson; Kishore M Gadde; John A Fairbank; K Ranga Rama Krishnan; Robert M Califf; Cynthia Binanay; Corette B Parker; Norma Pugh; Tyler D Hartwell; Benedetto Vitiello; Louise Ritz; Joanne Severe; Jonathan O Cole; Charles de Battista; P Murali Doraiswamy; John P Feighner; Paul Keck; Jeffrey Kelsey; Khae-Ming Lin; Peter D Londborg; Charles B Nemeroff; Alan F Schatzberg; David V Sheehan; Ram K Srivastava; Leslie Taylor; Madhukar H Trivedi; Richard H Weisler
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

9.  Testing differences in response trends across a normalized time domain.

Authors:  J E Overall; C Shivakumar
Journal:  J Clin Psychol       Date:  1999-07
  9 in total
  1 in total

1.  Computer-based self-training for CT colonography with and without CAD.

Authors:  Lapo Sali; Silvia Delsanto; Daniela Sacchetto; Loredana Correale; Massimo Falchini; Andrea Ferraris; Giovanni Gandini; Giulia Grazzini; Franco Iafrate; Gabriella Iussich; Lia Morra; Andrea Laghi; Mario Mascalchi; Daniele Regge
Journal:  Eur Radiol       Date:  2018-05-23       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.